Polarean Imaging submits new protocol to FDA for expanded Xenoview use
(Alliance News) - Polarean Imaging PLC on Tuesday said it has submitted a new phase 3 clinical trial protocol to the US Food & Drug Administration, to support an expanded remit for Xenoview. Read More